Perren Fabienne, Loulidi Jaouad, Poglia Davide, Landis Theodor, Sztajzel Roman
Department of Neurology, Neurosonology Unit, HUG, University Hospital and Medical School of Geneva, Micheli-du-Crest 24, 1211 Geneva 14, Switzerland.
J Thromb Thrombolysis. 2008 Apr;25(2):219-23. doi: 10.1007/s11239-007-0044-6. Epub 2007 May 20.
We studied whether 2 MHz transcranial color-coded duplex ultrasound (TCCD), combined with a second generation ECA, accelerate IV rtPA-thrombolysis in the acute phase of MCA stroke more than TCCD monitoring alone.
Non-randomized acute MCA stroke patients undergoing IV rtPA-thrombolysis and 2 MHZ-TCCD monitoring over 60 min, with (N = 11) or without (N = 15) additional continuous ECA (5 ml, SonoVue perfusion, were compared. Recanalization of the MCA was measured pre- and post-thrombolysis with the thrombolysis in brain ischemia (TIBI) grading system, clinical outcome was assessed at admission and 24 h after treatment using the NIH stroke scale (NIHSS).
Patients who received ECA improved their NIHSS significantly more than those who were only TCCD monitored (Mann-Whitney U = 48.0; P = 0.050), and their flow signal improved more (Mann-Whitney U = 40.0; P < 0.03).
The results of this pilot study show that in IV-thrombolysis the use of ECA in addition to TCCD monitoring lead to a greater immediate clinical improvement and to a better flow signal.
我们研究了2兆赫经颅彩色编码双功超声(TCCD)联合第二代增强对比剂(ECA),与单独使用TCCD监测相比,是否能在大脑中动脉(MCA)卒中急性期更有效地加速静脉注射重组组织型纤溶酶原激活剂(rtPA)溶栓治疗。
对接受静脉rtPA溶栓治疗并进行60分钟2兆赫TCCD监测的非随机急性MCA卒中患者进行比较,其中一组(N = 11)额外接受连续ECA(5毫升,声诺维灌注),另一组(N = 15)不接受。在溶栓前后使用脑缺血溶栓(TIBI)分级系统测量MCA再通情况,在入院时和治疗后24小时使用美国国立卫生研究院卒中量表(NIHSS)评估临床结局。
接受ECA的患者NIHSS改善程度显著高于仅接受TCCD监测的患者(曼-惠特尼U检验= 48.0;P = 0.050),其血流信号改善也更明显(曼-惠特尼U检验= 40.0;P < 0.03)。
这项初步研究结果表明,在静脉溶栓治疗中,除TCCD监测外使用ECA可带来更大的即时临床改善和更好的血流信号。